HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CTVA

Corteva, Inc. (S&P 500)

Basic Materials — Agricultural Inputs

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. The company was founded in 1802 and is headquartered in Indianapolis, Indiana.

Buy 1.8 / 5 20 analysts
$88.95
+$1.37 (+1.56%)
Target: $91.40 (2.8%)
Sign in to add CTVA to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$59.49B
P/E Ratio (TTM)48.08
Forward P/E21.50
EPS (TTM)$1.85
Dividend Yield0.82%
Profit Margin6.50%
Revenue Growth11.00%
ROE5.14%
Debt/Equity13.64
Recommendation Buy 1.8
Analyst Target$91.40
Analysts20
Indexes S&P 500

Technical Indicators

RSI (14)63.4
Beta0.56
SMA 20$86.40
SMA 40$82.15
52-Week High$89.75
52-Week Low$60.54
50-Day Avg$81.56
200-Day Avg$74.74
Avg Volume$3.86M
Volume$4.64M

Performance Analysis

BULLISH

CTVA shows predominantly bullish signals based on its fundamentals and technicals.

- Trading near its 52-week high ($89.75), which may indicate limited upside.
+ RSI at 63.4 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 48.1 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 11.0% year-over-year.
+ Wall Street consensus is "Buy" from 20 analysts.
+ Average analyst target of $91.40 implies 2.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:00 UTC

Back to Screener Export Report